MML Investors Services
CLVS

MML Investors Services’s Clovis Oncology, Inc. CLVS Stock Holding History

MML Investors Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-72,135
Closed -$322K – 2082
2021
Q3 		$322K Buy
72,135
+25
+0% +$120 ﹤0.01% 1605
2021
Q2 		$418K Buy
72,110
+5,398
+8% +$31.6K ﹤0.01% 1416
2021
Q1 		$468K Sell
66,712
-70,588
-51% -$473K ﹤0.01% 1297
2020
Q4 		$659K Buy
137,300
+58,200
+74% +$294K 0.01% 1020
2020
Q3 		$461K Buy
79,100
+9,400
+13% +$56.2K 0.01% 1080
2020
Q2 		$470K Buy
69,700
+41,600
+148% +$315K 0.01% 1017
2020
Q1 		$179K Buy
+28,100
New +$225K ﹤0.01% 1296

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MML Investors Services's CLVS Position: Q4 2021 in Review

MML Investors Services sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 72,135 shares — an estimated $322K sold.

MML Investors Services first reported a position in CLVS in Q1 2020 and held it in 7 quarters. The position peaked at $659K in Q4 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • MML Investors Services reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • MML Investors Services sold 72,135 Clovis Oncology, Inc. shares in Q4 2021, an estimated $322K.
  • MML Investors Services first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 7 quarters.
  • MML Investors Services's Clovis Oncology, Inc. position peaked at $659K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on MML Investors Services's 13F filing for Q4 2021, filed 14 Feb 2022.